Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4945 total record number 0 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 389 out of 495
4945 citations found

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • Animals and Surgery:

    Male Sprague-Dawley rats (n = 9, 250430 g; Taconic Farms, Germantown, NY) were utilized for these experiments and all protocols were in accordance with the Institutional Animal Care and Use Committee at Oregon Health & Science University. Vagal afferents were identified using anterograde tracing following injection of Cholera Toxin B Subunit (CTb; 1 2 l; 1% in dH2O; List Biological Laboratories, Campbell, CA)…

    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Physical (in)activity-dependent structural plasticity in bulbospinal catecholaminergic neurons of rat rostral ventrolateral medulla.

Mischel, NA;Llewellyn-Smith, IJ;Mueller, PJ;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Anthrax lethal toxin inhibits translation of hypoxia-inducible factor 1 and causes decreased tolerance to hypoxic stress

Ouyang, W;Torigoe, C;Fang, H;Xie, T;Frucht, DM;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Die laterale Habenula

Schneider, K;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain

Cagli, D;Krutein, MC;Bompiani, KM;Barlow, DJ;Benoni, G;Pelletier, JC;Reitz, AB;Lairson, LL;Houseknecht, KL;Smith, GR;Dickerson, TJ;

Product: SNAPtide® Peptide Substrate (FITC/DABCYL) for C. botulinum Type A Neurotoxin

  • SNAPtide Assay:

    Inhibitory activity of small molecules from the compound libraries was determined by the decrease in BoNT/A LC enzymatic activity toward the SNAPtide uorogenic substrate (List Biological Laboratories). The assay was performed in 40 mM Hepes, pH 7.4, 0.01% Tween-20 at room temperature (22 C). In dose response IC50 assays, 9 point 1:3 dilutions of compounds in DMSO (1 L) were preincubated with 10 L of 70 nM BoNT/A LC (expressed in Escherichia coli and puried as described elsewhere22) in 79L of 40 mM Hepes buer in a 96-well black plate (Greiner) for 5 min at room temperature…

Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation

Ding, Z;Mathur, V;Ho, PP;James, ML;Lucin, KM;Hoehne, A;Alabsi, H;Gambhir, SS;Steinman, L;Luo, J;Wyss-Coray, T;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

CD14 mediates binding of high doses of LPS but is dispensable for TNF- production

Borzcka, K;Pciennikowska, A;Bjrkelund, H;Sobota, A;Kwiatkowska, K;

Product: ULTRA PURE LPS from Escherichia coli O111:B4

  • Cell Culture and Stimulation:

    RAW264 and J774A.1cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS) at 5% CO2. Cells were stimulated with ultrapure smooth LPS (sLPS) from E. coli 0111:B4 (List Biological Laboratories) …

Dominant effects of the diet on the microbiome and the local and systemic immune response in mice

Ooi, JH;Waddell, A;Lin, YD;Albert, I;Rust, LT;Holden, V;Cantorna, MT;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen

Lynch, HE;Stewart, SM;Kepler, TB;Sempowski, GD;Alam, SM;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Immunizations and serum isolation:

    Groups of eighteen (18) female C57Bl/6 (National Cancer Institute/Charles River Laboratories, Wilmington, MA) mice at 8-12 weeks of age were subcutaneously immunized with saline, 5 g recombinant anthrax protective antigen (rPA; List Biological Laboratories, Inc., Campbell, CA) alone or with 1.3 mg alum (Alhydrogel; Sigma, St. Louis, MO). On day 71 post-immunization, three mice from each group were given a boost of rPA (no adjuvant) at the same dose as the primary immunization …